M1FG
XERS icon

Mach-1 Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History

Mach-1 Financial Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52,530
Closed -$288K – 310
2025
Q1 		$288K Buy
+52,530
New +$212K 0.09% 208

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mach-1 Financial Group's XERS Position: Q2 2025 in Review

Mach-1 Financial Group sold out of Xeris Biopharma Holdings (XERS) in Q2 2025, closing a stake of 52,530 shares — an estimated $288K sold.

Mach-1 Financial Group first reported a position in XERS in Q1 2025 and held it in 1 quarter. The position peaked at $288K in Q1 2025. 200 funds tracked by Wall St. Rank hold XERS as of Q2 2025.

  • Mach-1 Financial Group reported no remaining Xeris Biopharma Holdings position as of Q2 2025 after selling out during the quarter.
  • Mach-1 Financial Group sold 52,530 Xeris Biopharma Holdings shares in Q2 2025, an estimated $288K.
  • Mach-1 Financial Group first reported a position in Xeris Biopharma Holdings in Q1 2025 and held it in 1 quarter.
  • Mach-1 Financial Group's Xeris Biopharma Holdings position peaked at $288K in Q1 2025.
  • 200 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2025.

Based on Mach-1 Financial Group's 13F filing for Q2 2025, filed 11 Aug 2025.